The CAPE Study

  • Research type

    Research Study

  • Full title

    Prognostic utility of cardiovascular biomarkers in women with pre-eclampsia - the CAPE study

  • IRAS ID

    253937

  • Contact name

    Phyo Myint

  • Contact email

    phyo.myint@abdn.ac.uk

  • Sponsor organisation

    University of Aberdeen

  • Duration of Study in the UK

    1 years, 6 months, 1 days

  • Research summary

    Pre-eclampsia is a pregnancy complication characterised by high blood pressure and signs of damage to another organ system, most often the liver and kidneys. Pre-eclampsia usually begins after 20 weeks of pregnancy in women whose blood pressure had been normal. It is associated with an increased risk of developing heart disease later in life. At present, little is known about the prevention of heart disease in women suffering from pre-eclampsia during their pregnancy. The purpose of this study is to make recommendations for follow-up tests in women with pre-eclampsia well before the onset of heart disease and to influence international guidelines, which in turn has the potential to influence the treatment and long term follow up of women with pre-eclampsia. We are interested in studying women who have had a normal pregnancy as well as those who have had preeclampsia. \n\n

  • REC name

    North of Scotland Research Ethics Committee 1

  • REC reference

    18/NS/0131

  • Date of REC Opinion

    3 Dec 2018

  • REC opinion

    Favourable Opinion